Thoracic Imaging 2003 - Society of Thoracic Radiology

REFERENCES
Bavelaar-Croon CDL, Atsma DE, Van Der Wall EE, et al. The
additive value of Gated SPECT Myocardial Perfusion Imaging
on Patients with Known and Suspected Coronary Artery
Disease. Nucl Med Commun.2001;22:45-55.
Bengel FM, Schwaiger M. Nuclear Medicine Studies of the Heart.
Eur Radiol. 1998;8:1698-1706.
Cacciabando JM, Szulc M. Gated Cardiac SPECT: Has the
Addition of Function to Perfusion Strengthened the Value of
Myocardial Perfusion Imaging?. J Nucl Med. 2001; 42
(7):1050-2.
Cerqueira MD, Lawrence A. Nuclear Cardiology Update. Radiol
Clin North Am 2001; 39(5): 931-46.
Cuocolo A, Acampa W. Nuclear Cardiology in the New Millenium.
Rev Esp Med Nucl 2001; 20: 305-308.
De Puey EG, Garcia EV, Berman DS. Cardiac SPECT Imaging.
2nd Edition. Lippincott, Williams & Wilkins. 2001.
Matte GG, Barnes DC, Abrams DN. Pharmacological
Interventions in Nuclear Medicine Assessment of Cardiac
Perfusion. J Pharm Pharmaceut Sci. 2001; 4(3): 255-62.
Schafers M, Schober O, Lerch H. Cardiac Sympathetic
Neurotransmission Scintigraphy. Eur J Nucl Med. 1998; 25:
435-41.
Schinkel AF, Bax JJ, Sozzi FB, et al. Prevalence of Myocardial
Viability Assessed by Single Photon Emission Computed
Tomography in Patients with Chronic Ischaemic Left
Ventricular Dysfunction. Heart: 2002; 88(2): 125-30.
Schwaiger M, Melin J. Cardiological Applications of Nuclear
Medicine. Lancet. 1999; 354(6): 61-66.
155
TUESDAY